News
Trent Reutiman, chief executive officer of Anaconda Biomed, added, “The ATHENA clinical trial marks the next important step in advancing our funnel catheter technology for ischemic stroke and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback